Chronic mucocutaneous candidiasis (CMC) is a monogenetic immunodeficiency of cell-mediated immunity that develops as a consequence of defects in IL-17 and IL-22 immunity required for defence against fungal infections [43]. Here, IL17A is linked to fungal infectious disease.